Pearson JD - Search Results

1

Nonsteroidal anti-inflammatory drugs and risk of prostate cancer in the Baltimore Longitudinal Study of Aging.

Platz EA, Rohrmann S, Pearson JD, Corrada MM, Watson DJ, De Marzo AM, Landis PK, Metter EJ, Carter HB. Platz EA, et al. Among authors: pearson jd. Cancer Epidemiol Biomarkers Prev. 2005 Feb;14(2):390-6. doi: 10.1158/1055-9965.EPI-04-0532. Cancer Epidemiol Biomarkers Prev. 2005. PMID: 15734963

2

Estimation of prostatic growth using serial prostate-specific antigen measurements in men with and without prostate disease.

Carter HB, Morrell CH, Pearson JD, Brant LJ, Plato CC, Metter EJ, Chan DW, Fozard JL, Walsh PC. Carter HB, et al. Among authors: pearson jd. Cancer Res. 1992 Jun 15;52(12):3323-8. Cancer Res. 1992. PMID: 1375867

3

PSA velocity for the diagnosis of early prostate cancer. A new concept.

Carter HB, Pearson JD. Carter HB, et al. Among authors: pearson jd. Urol Clin North Am. 1993 Nov;20(4):665-70. Urol Clin North Am. 1993. PMID: 7505974

4

Percentage of free prostate-specific antigen in sera predicts aggressiveness of prostate cancer a decade before diagnosis.

Carter HB, Partin AW, Luderer AA, Metter EJ, Landis P, Chan DW, Fozard JL, Pearson JD. Carter HB, et al. Among authors: pearson jd. Urology. 1997 Mar;49(3):379-84. doi: 10.1016/s0090-4295(96)00629-2. Urology. 1997. PMID: 9123702 Free article.

5

Prostate-specific antigen velocity and repeated measures of prostate-specific antigen.

Carter HB, Pearson JD. Carter HB, et al. Among authors: pearson jd. Urol Clin North Am. 1997 May;24(2):333-8. doi: 10.1016/s0094-0143(05)70380-3. Urol Clin North Am. 1997. PMID: 9126231 Free article.

6

Prostate-specific antigen testing of older men.

Carter HB, Landis PK, Metter EJ, Fleisher LA, Pearson JD. Carter HB, et al. Among authors: pearson jd. J Natl Cancer Inst. 1999 Oct 20;91(20):1733-7. doi: 10.1093/jnci/91.20.1733. J Natl Cancer Inst. 1999. PMID: 10528023 Free PMC article.

7

Longitudinal evaluation of prostate-specific antigen levels in men with and without prostate disease.

Carter HB, Pearson JD, Metter EJ, Brant LJ, Chan DW, Andres R, Fozard JL, Walsh PC. Carter HB, et al. Among authors: pearson jd. JAMA. 1992 Apr 22-29;267(16):2215-20. JAMA. 1992. PMID: 1372942 Free PMC article.

8

Evaluation of serum prostate-specific antigen velocity after radical prostatectomy to distinguish local recurrence from distant metastases.

Partin AW, Pearson JD, Landis PK, Carter HB, Pound CR, Clemens JQ, Epstein JI, Walsh PC. Partin AW, et al. Among authors: pearson jd. Urology. 1994 May;43(5):649-59. doi: 10.1016/0090-4295(94)90180-5. Urology. 1994. PMID: 7513108

9

Mixed-effects regression models for studying the natural history of prostate disease.

Pearson JD, Morrell CH, Landis PK, Carter HB, Brant LJ. Pearson JD, et al. Stat Med. 1994 Mar 15-Apr 15;13(5-7):587-601. doi: 10.1002/sim.4780130520. Stat Med. 1994. PMID: 7517570

10

Natural history of changes in prostate specific antigen in early stage prostate cancer.

Pearson JD, Carter HB. Pearson JD, et al. J Urol. 1994 Nov;152(5 Pt 2):1743-8. doi: 10.1016/s0022-5347(17)32375-3. J Urol. 1994. PMID: 7523722 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

329 results

Search Page

Filters